Taylor & Francis
Pathogens And Global Health
(ISSN 2047-7732)
Aims and scope
Pathogens and Global Health is a journal of infectious disease and public health that focuses on the translation of molecular, immunological, genomics and epidemiological knowledge into control measures for global health threats. The journal publishes original innovative research papers, assesses and contextualises new ideas, trends and research, and interviews policy makers and opinion leaders on health subjects of international relevance. It provides a forum for scientific, ethical and political discussion of new innovative solutions for controlling and eradicating infectious diseases, with particular emphasis on those diseases affecting the poorest regions of the world.
PGH is currently particularly interested in original research and reviews that document the development of RNA vaccines, against SARS-CoV-2 and other infectious diseases, whether that is in relation to molecular science and delivery, clinical data and safety, or economics and scalability. For COVID-19 and beyond, we are also interested in the development of monoclonal antibody therapies, their mechanism and production, and their implementation and impact.
We are also currently interested in topics that come under these themes:
– Drug development
– Economic modelling/Cost-benefit analyses
– Emerging viral diseases
– Fungal infections
– New insecticides
– Tick-borne diseases
– Uses of public health data/precision medicine
– Vaccines/Potential vaccination candidates
– Vector control technology
PGH encourages submissions of the following article types:
Review articles:
Review Articles provide a comprehensive summary of research on a topic, and a perspective on the state of the field and where it is heading. PGH welcomes the submission of unsolicited reviews. However, to ensure that a review is within the scope and interest of the journal, the Editor recommends that you contact the editorial office at pathogengh@imperial.ac.uk to discuss the topic further.
Examples of recently published review articles:
The CRISPR revolution and its potential impact on global health security
A review of mechanistic models of viral dynamics in bat reservoirs for zoonotic disease
The impact of climate change on mosquito-borne diseases in Africa
Original Articles:
The journal welcomes detailed and thoroughly described original research* and should include the following headings: Introduction, Materials and Methods, Results, Discussion. The research should be in an area within an infectious disease or public health scope, and should be in an area of scientific importance. Research findings should be novel and be contextualised for an interdisciplinary readership.
Examples of recently published original articles:
Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalised patients with severe manifestations of SARS-CoV-2 infection
Why are Asian countries outperforming the Western world in controlling COVID-19 pandemic?
Cellular mechanisms regulating synthetic sex ratio distortion in the Anopheles gambiae germline
Commentaries:
The journal accepts commentaries, which are short articles on research, ideas, trends, innovations, and the implications of technological, political, policy and legal changes on topics of interest to infectious disease and public health communities. Commentaries should critically evaluate the topic from your perspective, giving it wider context. These papers should be between 500-1,000 words and up to 5 references.
Examples of recently published commentaries:
Genetic risks and association with severe COVID-19 among global populations
The COVID-19 pandemic in Brazil built on socioeconomic and political pillars
Decreased in-hospital mortality in patients with COVID-19 pneumonia
* Please note that the journal does not accept short communications at the initial submission stage. Short communications are only published in PGH when reviewers suggest that a submitted original article be published but only if it is re-formatted as a short communication. We also recommend that clinical papers are put into the context of their epidemiological or public health value – without this the journal is likely to recommend that it is submitted to a regional journal.
Authors can choose to publish gold open access in this journal.
Read the Instructions for Authors for information on how to submit your article.